Panel Q&A: Accelerating diagnostic test development

Molecular and immunodiagnostic tests using nucleic acid and protein-based assays are now an essential component in the evaluation and early detection of many diseases. Applications include the areas of infectious diseases, oncology, inherited disorders, and prediction of genetic disease risk, with new applications coming to market every day.  

Take advantage of Cytiva’s extensive experience and expertise from the design stage through launch to minimize costs and accelerate the timeline for commercialization. Our team of scientists and manufacturing specialists will work with your in-house teams to help you optimize components and identify the best-suited technologies. This enables you to expand your customer base and address new markets and applications that may previously have seemed out of reach. 

Join this panel Q&A session and hear our panel of Cytiva experts answering some of your most pressing questions.